Jazz Pharmaceuticals' Lung Cancer Setback: Stock Impact
A late-stage setback for Jazz Pharmaceuticals' lung cancer drug Zepzelca rattled investors, but the larger story may ...
Identify and prune unused or duplicative subscriptions with a simple audit. This intro covers tracking, prioritizing, and scaling back renewals.
19,895 articlesA late-stage setback for Jazz Pharmaceuticals' lung cancer drug Zepzelca rattled investors, but the larger story may ...
The ADA conference spotlighted Lilly and Novo Nordisk in the GLP-1 race. This deep dive explains what the claims mean...
A high-earning retiree with a large pension quietly unlocks Medicare’s IRMAA top tier. The result: higher monthly bil...
Divorced spouses rarely collect both benefits, because social security pays only the higher amount, not both. This ru...
Bitcoin trades near $58,000 after breaking below the $60,000 zone, triggering renewed concerns about the bitcoin pric...
The GENIUS Act's one-year rulemaking deadline lands on July 18, placing stablecoin issuers under intense regulatory s...
Remote work holds steady around 22% of US workers in early 2026, defying headlines of a mass office return. New data ...
As markets stabilize in 2026, a growing argument centers on placing the Vanguard Mid-Cap ETF (VO) inside a Roth IRA t...
Retirees can pause Social Security after reaching full retirement age to earn delayed credits and lift future payment...
NVIDIA has retreated from its AI-driven highs, creating a potential buying opportunity. This guide explains why the s...
Two popular small-cap growth ETFs—ISCG and RZG—take different paths to growth. This guide breaks down how they work, ...
Choosing between VEA and NZAC boils down to your priority: broad diversification in developed markets or a climate-al...